A biotechnology company focused on developing therapies targeting the transforming growth factor‑beta (TGF‑β) protein superfamily to treat serious and rare diseases. Its pipeline has centered on treatments for hematologic disorders and pulmonary conditions, including the anemia drug luspatercept, co...
2 members of Congress have disclosed 2 trades in Acceleron Pharma Incorporated (XLRN), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-07-22 | Ann Wagner | buy | $15K – $50K |
| 2015-10-06 | MIKE KELLY | buy | $1K – $15K |